15-LOX-1 transcription suppression through the NuRD complex in colon cancer cells (original) (raw)

• Ariel A, Serhan CN . (2007). Resolvins and protectins in the termination program of acute inflammation. Trends Immunol 28: 176–183.
  Article CAS PubMed Google Scholar
• Baer AN, Costello PB, Green FA . (1991). In vivo activation of an omega-6 oxygenase in human skin. Biochem Biophys Res Commun 180: 98–104.
  Article CAS PubMed Google Scholar
• Balasenthil S, Broaddus RR, Kumar R . (2006). Expression of metastasis-associated protein 1 (MTA1) in benign endometrium and endometrial adenocarcinomas. Hum Pathol 37: 656–661.
  Article CAS PubMed Google Scholar
• Bolden JE, Peart MJ, Johnstone RW . (2006). Anticancer activities of histone deacetylase inhibitors. Nat Rev Drug Discov 5: 769–784.
  Article CAS PubMed Google Scholar
• Brash AR, Boeglin WE, Chang MS . (1997). Discovery of a second 15S-lipoxygenase in humans. Proc Natl Acad Sci USA 94: 6148–6152.
  Article CAS PubMed PubMed Central Google Scholar
• Brehm A, Nielsen SJ, Miska EA, McCance DJ, Reid JL, Bannister AJ et al. (1999). The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth. EMBO J 18: 2449–2458.
  Article CAS PubMed PubMed Central Google Scholar
• Chen GG, Xu H, Lee JF, Subramaniam M, Leung KL, Wang SH et al. (2003). 15-hydroxy-eicosatetraenoic acid arrests growth of colorectal cancer cells via a peroxisome proliferator-activated receptor gamma-dependent pathway. Int J Cancer 107: 837–843.
  Article CAS PubMed Google Scholar
• Conrad DJ, Lu M . (2000). Regulation of Human 12/15-Lipoxygenase by Stat6-Dependent Transcription. Am J Respir Cell Mol Biol 22: 226–234.
  Article CAS PubMed Google Scholar
• Deguchi A, Xing SW, Shureiqi I, Yang P, Newman RA, Lippman SM et al. (2005). Activation of protein kinase G up-regulates expression of 15-lipoxygenase-1 in human colon cancer cells. Cancer Res 65: 8442–8447.
  Article CAS PubMed Google Scholar
• Furumai R, Matsuyama A, Kobashi N, Lee KH, Nishiyama M, Nakajima H et al. (2002). FK228 (depsipeptide) as a natural prodrug that inhibits class I histone deacetylases. Cancer Res 62: 4916–4921.
  CAS PubMed Google Scholar
• Giannini R, Cavallini A . (2005). Expression analysis of a subset of coregulators and three nuclear receptors in human colorectal carcinoma. Anticancer Res 25: 4287–4292.
  CAS PubMed Google Scholar
• Gibbs JB . (2000). Mechanism-based target identification and drug discovery in cancer research. Science 287: 1969–1973.
  Article CAS PubMed Google Scholar
• Gleason MM, Rojas CJ, Learn KS, Perrone MH, Bilder GE . (1995). Characterization and inhibition of 15-lipoxygenase in human monocytes: comparison with soybean 15-lipoxygenase. Am J Physiol 268: C1301–C1307.
  Article CAS PubMed Google Scholar
• Hennig R, Kehl T, Noor S, Ding XZ, Rao SM, Bergmann F et al. (2007). 15-Lipoxygenase-1 Production is Lost in Pancreatic Cancer and Overexpression of the Gene Inhibits Tumor Cell Growth. Neoplasia 9: 917–926.
  Article CAS PubMed PubMed Central Google Scholar
• Heslin MJ, Hawkins A, Boedefeld W, Arnoletti JP, Frolov A, Soong R et al. (2005). Tumor-associated down-regulation of 15-lipoxygenase-1 is reversed by celecoxib in colorectal cancer. Ann Surg 241: 941–946, (Discussion 946–947).
  Article PubMed PubMed Central Google Scholar
• Hsi LC, Xi X, Lotan R, Shureiqi I, Lippman SM . (2004). The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis via induction of 15-lipoxygenase-1 in colorectal cancer cells. Cancer Res 64: 8778–8781.
  Article CAS PubMed Google Scholar
• Hsi LC, Xi X, Wu Y, Lippman SM . (2005). The methyltransferase inhibitor 5-aza-2-deoxycytidine induces apoptosis via induction of 15-lipoxygenase-1 in colorectal cancer cells. Mol Cancer Ther 4: 1740–1746.
  Article CAS PubMed Google Scholar
• Huang BH, Laban M, Leung CHW, Lee L, Lee CK, Salto-Tellez M et al. (2005). Inhibition of histone deacetylase 2 increases apoptosis and p21Cip1//WAF1 expression, independent of histone deacetylase 1. Cell Death Differ 12: 395–404.
  Article CAS PubMed Google Scholar
• Jiang WG, Watkins G, Douglas-Jones A, Mansel RE . (2006). Reduction of isoforms of 15-lipoxygenase (15-LOX)-1 and 15-LOX-2 in human breast cancer. Prostaglandins Leukot Essent Fatty Acids 74: 235–245.
  Article CAS PubMed Google Scholar
• Kamitani H, Geller M, Eling T . (1998). Expression of 15-lipoxygenase by human colorectal carcinoma Caco-2 cells during apoptosis and cell differentiation. J Biol Chem 273: 21569–21577.
  Article CAS PubMed Google Scholar
• Kamitani H, Kameda H, Kelavkar UP, Eling TE . (2000). A GATA binding site is involved in the regulation of 15-lipoxygenase-1 expression in human colorectal carcinoma cell line, caco-2. FEBS Lett 467: 341–347.
  Article CAS PubMed Google Scholar
• Kamitani H, Taniura S, Ikawa H, Watanabe T, Kelavkar UP, Eling TE . (2001). Expression of 15-lipoxygenase-1 is regulated by histone acetylation in human colorectal carcinoma. Carcinogenesis 22: 187–191.
  Article CAS PubMed Google Scholar
• Li J, Wang J, Wang J, Nawaz Z, Liu JM, Qin J et al. (2000). Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3. EMBO J 19: 4342–4350.
  Article CAS PubMed PubMed Central Google Scholar
• Liu C, Xu D, Sjoberg J, Forsell P, Bjorkholm M, Claesson HE . (2004). Transcriptional regulation of 15-lipoxygenase expression by promoter methylation. Exp Cell Res 297: 61–67.
  Article CAS PubMed Google Scholar
• Manavathi B, Kumar R . (2007). Metastasis tumor antigens, an emerging family of multifaceted master coregulators. J Biol Chem 282: 1529–1533.
  Article CAS PubMed Google Scholar
• Marks PA, Richon VM, Miller T, Kelly WK . (2004). Histone Deacetylase Inhibitors. Adv Cancer Res 91: 137–168.
  Article CAS PubMed Google Scholar
• Nixon JB, Kim KS, Lamb PW, Bottone FG, Eling TE . (2004). 15-Lipoxygenase-1 has anti-tumorigenic effects in colorectal cancer. Prostaglandins Leukot Essent Fatty Acids 70: 7–15.
  Article CAS PubMed Google Scholar
• Ostareck DH, Ostareck-Lederer A, Wilm M, Thiele BJ, Mann M, Hentze MW . (1997). mRNA Silencing in Erythroid Differentiation: hnRNP K and hnRNP E1 Regulate 15-Lipoxygenase Translation from the 3' End. Cell 89: 597–606.
  Article CAS PubMed Google Scholar
• Serhan CN, Jain A, Marleau S, Clish C, Kantarci A, Behbehani B et al. (2003). Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators. J Immunol 171: 6856–6865.
  Article CAS PubMed Google Scholar
• Shankaranarayanan P, Chaitidis P, Kuhn H, Nigam S . (2001). Acetylation by histone acetyltransferase CREB-binding protein/p300 of STAT6 is required for transcriptional activation of the 15-lipoxygenase-1 gene. J Biol Chem 276: 42753–42760.
  Article CAS PubMed Google Scholar
• Sharma D, Saxena NK, Davidson NE, Vertino PM . (2006). Restoration of tamoxifen sensitivity in estrogen receptor-negative breast cancer cells: tamoxifen-bound reactivated ER recruits distinctive corepressor complexes. Cancer Res 66: 6370–6378.
  Article CAS PubMed PubMed Central Google Scholar
• Shureiqi I, Chen D, Lee JJ, Yang P, Newman RA, Brenner DE et al. (2000a). 15-LOX-1: a novel molecular target of nonsteroidal anti-inflammatory drug-induced apoptosis in colorectal cancer cells. J Natl Cancer Inst 92: 1136–1142.
  Article CAS PubMed Google Scholar
• Shureiqi I, Chen D, Lotan R, Yang P, Newman RA, Fischer SM et al. (2000b). 15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells. Cancer Res 60: 6846–6850.
  CAS PubMed Google Scholar
• Shureiqi I, Jiang W, Fischer SM, Xu X, Chen D, Lee JJ et al. (2002). GATA-6 transcriptional regulation of 15-lipoxygenase-1 during NSAID-induced apoptosis in colorectal cancer cells. Cancer Res 62: 1178–1183.
  CAS PubMed Google Scholar
• Shureiqi I, Jiang W, Zuo X, Wu Y, Stimmel JB, Leesnitzer LM et al. (2003). The 15-lipoxygenase-1 product 13-S-hydroxyoctadecadienoic acid down-regulates PPAR-delta to induce apoptosis in colorectal cancer cells. Proc Natl Acad Sci USA 100: 9968–9973.
  Article CAS PubMed PubMed Central Google Scholar
• Shureiqi I, Wojno KJ, Poore JA, Reddy RG, Moussalli MJ, Spindler SA et al. (1999). Decreased 13-S-hydroxyoctadecadienoic acid levels and 15-lipoxygenase-1 expression in human colon cancers. Carcinogenesis 20: 1985–1995.
  Article CAS PubMed Google Scholar
• Shureiqi I, Wu Y, Chen D, Yang XL, Guan B, Morris JS et al. (2005). The critical role of 15-lipoxygenase-1 in colorectal epithelial cell terminal differentiation and tumorigenesis. Cancer Res 65: 11486–11492.
  Article CAS PubMed PubMed Central Google Scholar
• Shureiqi I, Xu X, Chen D, Lotan R, Morris JS, Fischer SM et al. (2001). Nonsteroidal anti-inflammatory drugs induce apoptosis in esophageal cancer cells by restoring 15-lipoxygenase-1 expression. Cancer Res 61: 4879–4884.
  CAS PubMed Google Scholar
• Shureiqi I, Zuo X, Broaddus R, Wu Y, Guan B, Morris JS et al. (2007). The transcription factor GATA-6 is overexpressed in vivo and contributes to silencing 15-LOX-1 in vitro in human colon cancer. FASEB J 21: 743–753.
  Article CAS PubMed Google Scholar
• Takamitsu S, Kiyomu F, Kazuhiro Y, Hideo S, Tomonori S, Hitoshi O et al. (2006). Peritoneal metastasis inhibition by linoleic acid with activation of PPARã in human gastrointestinal cancer cells. Virchows Archiv 448: 422–427.
  Article Google Scholar
• Takata S, Matsubara M, Allen PG, Janmey PA, Serhan CN, Brady HR . (1994). Remodeling of neutrophil phospholipids with 15(S)- hydroxyeicosatetraenoic acid inhibits leukotriene B4-induced neutrophil migration across endothelium. J Clin Invest 93: 499–508.
  Article CAS PubMed PubMed Central Google Scholar
• Wu J, Xia HH, Tu SP, Fan DM, Lin MC, Kung HF et al. (2003). 15-Lipoxygenase-1 mediates cyclooxygenase-2 inhibitor-induced apoptosis in gastric cancer. Carcinogenesis 24: 243–247.
  Article CAS PubMed Google Scholar
• Wu Y, Fang B, Yang XQ, Wang L, Chen D, Krasnykh V et al. (2008). Therapeutic molecular targeting of 15-lipoxygenase-1 in colon cancer. Mol Ther 16: 886–892.
  Article CAS PubMed Google Scholar
• Xue Y, Wong J, Moreno GT, Young MK, Cote J, Wang W . (1998). NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities. Mol Cell 2: 851–861.
  Article CAS PubMed Google Scholar
• Zhang C, Richon V, Ni X, Talpur R, Duvic M . (2005a). Selective induction of apoptosis by Histone deacetylase inhibitor SAHA in cutaneous T-cell lymphoma cells: relevance to mechanism of therapeutic action. J Investig Dermatol 125: 1045–1052.
  Article CAS PubMed Google Scholar
• Zhang X-y, DeSalle LM, Patel JH, Capobianco AJ, Yu D, Thomas-Tikhonenko A et al. (2005b). Metastasis-associated protein 1 (MTA1) is an essential downstream effector of the c-MYC oncoprotein. PNAS 102: 13968–13973.
  Article CAS PubMed PubMed Central Google Scholar
• Zhu P, Martin E, Mengwasser J, Schlag P, Janssen KP, Gottlicher M . (2004). Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis. Cancer Cell 5: 455–463.
  Article CAS PubMed Google Scholar
• Zuo X, Shen L, Issa J-P, Moy O, Morris JS, Lippman SM et al. (2008). 15-Lipoxygenase-1 transcriptional silencing by DNA methyltransferase-1 independently of DNA methylation. FASEB J 22: 1981–1992.
  Article CAS PubMed Google Scholar
• Zuo X, Wu Y, Morris JS, Stimmel JB, Leesnitzer LM, Fischer SM et al. (2006). Oxidative metabolism of linoleic acid modulates PPAR-beta/delta suppression of PPAR-gamma activity. Oncogene 25: 1225–1241.
  Article CAS PubMed PubMed Central Google Scholar